QUETIAPINE
Active substance: quetiapine
TABLET, EXTENDED RELEASE · QUETIAPINE 50 mg/1
United StatesActive
Marketing holder: Solco Healthcare U.S., LLC
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
- QUETIAPINE · 50 mg/1
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 62 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-3175-7b03-a517-a29c833a8e7a,01a120c3-3734-7d8e-bc64-504091932df0,01a120c3-3cbe-7a77-bacb-b04527a3c825,01a120c3-4160-7274-a36f-31abc3a1b143,01a120c3-4167-704d-873a-bd2a2b66859b;count=45 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-2740-7cc1-afad-629e53143837,01a1208c-29da-7026-bdea-53d600954d56,01a1208c-3119-7696-8f5d-0dbe2a476a28,01a1208c-311a-750e-9783-15b319b44ed2,01a1208c-351e-7acc-908c-df930bc3893a;count=348 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- 43547-019
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
- product · openFDA NDC · 43547-019 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 43547-019 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 43547-019 · Verified 2026-10-09 · open in source